• Confirmation
  of partner
  company's needs
  for entering Japan

• PIPELINE inspection

• 1st selection of items
  for entering Japan

• Item review

• Development
  for entering
  Japan in progress

• Proposed products by Japanese partners
• Proposed products by OHSONG PHARM
• Products for review requested from domestic companies
• Our products/products under development by domestic companies

The first product in the domestic pharmaceutical industry to obtain approval from the Japanese PMDA.
Osteoporosis treatment

Product	제품사진	API	Package	Batch size
Ibandronate Syringes Intravenous Injection 1 mg 「VTRS」		Ibandronate Sodium Hydrate	1 mL x 1 Syringes, 1 mL x 10 Syringes	80,000 Syringes